Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 6.4% | 3,351,425 | 0 | 3,351,425 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 6.4% | 3,351,425 | 0 | 3,351,425 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.9% | 1,505,307 | 0 | 1,505,307 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.9% | 1,505,307 | 0 | 1,505,307 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.6% | 306,903 | 0 | 306,903 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.6% | 306,903 | 0 | 306,903 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.2% | 4,856,732 | 0 | 4,856,732 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 5,263,541 | 0 | 5,263,541 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 5,263,541 | 0 | 5,263,541 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 5,263,541 | 0 | 5,263,541 | /s/ Mark N. Lampert | Mark N. Lampert |